Updates on perioperative cessation of #SGLT2i Yael Tobi Harris Northwell Department of Medicine bjanaesthesia.org/article/S0007-…

#CGM improves detection of glycemic excursions in hemodialysis patients with #T2D CGM improved the detection of hyper & hypo, p nocturnal and prolonged hypos academic.oup.com/jcem/article-a…

Practical tips on how to #screen for early stage #type1diabetes ⁦Natalie Bellini⁩ ⁦Dr. Cristy Geno Rasmussen⁩ ⁦Endocrine Society Journals⁩ #JCEM ⁦Breakthrough T1D⁩ ⁦AACE⁩ ⁦Endocrine Society⁩ ⁦American Diabetes Association⁩ academic.oup.com/jcem/advance-a…

Registration and housing are open for the AACE Annual Meeting happening May 15-17, 2025, in Orlando, FL. Register now and save with advanced pricing: aace.com/2025 #AACE2025 #endocrinology

Really enjoyed making this podcast with Diana Isaacs, PharmD, BC-ADM, CDCES and Natalie Bellini on bringing #T1D screening to clinical practice as well as discussing efforts at Northwell Health Northwell Department of Medicine Yael Tobi Harris

I’m so excited about @theaace Annual Meeting, May 15–17 in Orlando, FL, with the theme: Endocrine Innovation & Obesity Breakthroughs with the Keynote lecture by Daniel J Drucker. Read my letter on touchENDOCRINOLOGY. touchendocrinology.com/insight/aace-2…

This picture of Yael Tobi Harris moderating a session on NP Endocrine Fellowship training AACE conference made me smile 😊

Congratulations to this year’s Annual Meeting Chair, Dr. Cecilia Low Wang! 🎉 Your leadership and dedication made our meeting a huge success. Thank you for bringing everyone together and inspiring us all!

Enjoyed speaking on #perioperative challenges of #SGLT2i and #GLP1RA AACE #AACE2025 #WeAreAACE Northwell Department of Medicine Yael Tobi Harris

Women who lead. #AACE2025 Northwell Health #HoustonMethodistHospital Archana Sadhu Rifka Schulman-Rosenbaum, MD, FACE, FACP #Endocrinology

That's a Wrap! Thank you for attending #AACE2025. See you in Las Vegas for AACE 2026. youtu.be/jrMszIKxOFI

Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: multidisciplinary consensus statement bjanaesthesia.org/article/S0007-… AACE American Diabetes Association The Obesity Society

Proud of our #inpatient #diabetes team! Watch video to learn about our work.

Summary of REDEFINE 1 and REDEFINE 2 trials with CagriSema, presented this week at #ADA2025 and published in NEJM: REDEFINE 1: • 👥 3,417 participants with obesity or overweight (without diabetes) treated with CagriSema achieved a 22.7% weight loss after 68 weeks, compared to

Breakthrough T1D And Mattel Release First-Ever Barbie With Type 1 Diabetes via @forbes forbes.com/sites/gabbysha…

Slower, flexible titration of semaglutide in 104 people with #T2D studied over 26 weeks improved adherence and reduced adverse events without compromising efficacy diabetesjournals.org/care/article/d…

Our review on the advances in treatment of osteoporosis 👇🏼 Sundeep Khosla Dominik Saul Mayo Clinic Endocrinology

First GIP/GLP-1 dual agonist tirzepatide showed CV protection in pp type 2 diabetes and heart disease ⁦⁦Eli Lilly and Company⁩ Second: all-cause mortality 16% lower for Mounjaro vs. Trulicity (hazard ratio: 0.84; 95.0% CI: 0.75 to 0.94) investor.lilly.com/news-releases/…

Top line results of the SURPASS-CVOT were announced! Tirzepatide went head to head vs dulaglutide and found to have less CV events including 16% lower rate of all cause death!

From #T2D to #obesity #CVD #OSA and now #MASH The expanding benefits of GLP-1 medicines novonordisk.com/news-and-media…